- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
- 10-K Annual report
- 10.1.5 Form of 2007 Restricted Stock Award Agreement
- 10.4 Form of Indemnification Agreement
- 10.9.6 Sixth Amendment to Lease Agreement
- 10.10 Consent to Assignment of Lease Agreement
- 10.11 First Amendment to Consent of Sublease Agreement
- 10.14 Side Letter
- 10.15 Antigenics Consent Agreement
- 10.18.1 Amendment No. 1,2,3,5,6 and 7 to Exclusive License Agreement with Aronex Pharm.
- 10.19 Amended & Restated License Agreement
- 10.28 2004 Executive Incentive Plan
- 23 Consent of KPMG LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO & CFO Pursuant to Section 906
Exhibit 32.1
Certification
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of Antigenics Inc. (the “Company”) for the year ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned to his/her knowledge hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(i) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ GARO H. ARMEN, PH.D. |
Garo H. Armen, Ph.D. |
Chief Executive Officer |
/s/ SHALINI SHARP |
Shalini Sharp |
Chief Financial Officer |
March 14, 2008
A signed original of this written statement required by Section 906 has been provided to Antigenics Inc. and will be retained by Antigenics Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2007 and should not be considered filed as part of the Annual Report on Form 10-K.